- No strong opportunity cluster is confirmed yet; monitor trend and activity pressure.
APN
JNB
Week ended 07 Aug 2026
Weekly Investor Report
Aspen Pharmacare Holdings Limited · Healthcare · Drug Manufacturers - Specialty & Generic
Latest close
152.2 ZAC
2.1%
latest week
Weekly setup
Mixed setup
The weekly trend is not active. Price is -98.3% below the Trend Line and sits at 0.1% of its 52-week range. The latest completed week returned 2.1%, after a 0.8% four-week move. The latest news-sentiment score is 51/100.
Setup score
28
out of 100
Latest Close
152.2 ZAC
7 Aug 2026
1W Return
2.1%
latest completed week
4W Return
0.8%
short-term follow-through
12W Return
-98.9%
quarterly tape
Trend Breadth
30.8%
16 of 52 weeks active
Volume Ratio
1.5x
vs 13-week average
- The trend backdrop is inactive, so price action has not confirmed a constructive regime.
- Price is below the Trend Line, which keeps downside pressure in focus.
- Price is below Fair Value, so the market is still discounting the latest tape.
- Activity pressure is negative, which weakens the current setup.
- Trend Line remains the key weekly regime level.
- Activity pressure is the gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through
2.1%
Latest completed week; four-week move 0.8%.
Indicator stack
17/38
Trend and activity pressure are weighted against the latest 12-week confirmation window.
Trend backdrop
Active
The trend backdrop defines the current weekly regime.
Patient Capital
Quiet
Activity-pressure buy-signal status for institutional accumulation timing.
News sentiment
51/100
20 relevant articles in the latest sentiment read.
01 · Price action
Study the full chart
Where price is—and whether the trend supports it
The weekly trend is not active. Price is -98.3% below the Trend Line and sits at 0.1% of its 52-week range. The latest completed week returned 2.1%, after a 0.8% four-week move.
52-week price path
Price vs Trend Line and Fair Value
Price
Trend Line
Fair Value
02 · Volume and demand
Is real participation confirming the move?
Latest weekly volume is 1.5x the 13-week average. Participation is unusually strong and confirms that the move is attracting attention.
26-week volume confirmation
Bar height shows volume; colour shows the weekly price direction
13 Feb
20 Feb
27 Feb
6 Mar
13 Mar
20 Mar
27 Mar
3 Apr
10 Apr
17 Apr
24 Apr
1 May
8 May
15 May
22 May
29 May
5 Jun
12 Jun
19 Jun
26 Jun
3 Jul
10 Jul
17 Jul
24 Jul
31 Jul
7 Aug
Up week
Down week
Demand beneath price
Activity pressure and institutional-style signals
These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.
Activity pressure path
Latest 0.2312-week average 0.63
12-week confirmation
Trend active2/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure2/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership2/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.23Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers
No recent accumulation markers. No reversal markers.
03 · Momentum and leadership
Is performance persistent—and is the stock leading?
Performance is 0.8% over four weeks, -98.9% over 12 weeks, and -98.6% over one year. The current trend has remained active for 0 consecutive weeks.
Performance by holding period
Active trend streak0 weeks
Active weeks in one year16
Trend breadth30.8%
Activity pressure vs relative leadership
Activity pressureRelative leadership
Pressure-0.88Latest activity-pressure read.
Pressure change43.6%Four-week change in activity pressure.
Leadership-98.42Latest relative-leadership reading.
RS change0.1%Four-week change in relative leadership.
04 · Fundamentals and valuation
Open full factor analysis
What investors are paying for—and the quality behind it
A published fundamentals and factor snapshot is not available for this company.
No published fundamental snapshot is available for this company.
05 · Ownership, options, and sentiment
What other market participants are doing
Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.
Insider activity-
No recent insider transactions are stored for this company.
News sentiment51/100
Weighted news tone is neutral across 20 relevant articles.
4 positive · 14 neutral · 2 negativePatient CapitalQuiet
Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal
06 · Catalysts and risk
What can move the shares—and how volatile the path has been
Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.
Next earnings-No event is currently stored.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-99.0%Distance below the 52-week high.
13-week volatility26.7%Standard deviation of weekly returns.
Weekly gains and losses
Latest 26 completed weeksEach bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.
13 Feb
13 Mar
10 Apr
8 May
5 Jun
3 Jul
7 Aug
Weeks higher15 of 2611 weeks finished lower.
Best week+12.5%Week of 13 Feb.
Worst week-99.0%Week of 5 Jun.
Latest week+2.1%Week of 7 Aug.
Shape of recent returns
Strong gains7
Modest gains8
Flat weeks0
Modest losses7
Sharp losses4
Recent vol26.7%13-week weekly-return volatility.
Base vol14.5%52-week weekly-return volatility.
Up/down split27/25Count of positive and negative weeks in the 52-week window.
Average skew4.0% / -6.8%Average positive week versus average negative week.
07 · Sector and peer context
Is this stock leading—or simply moving with its group?
Sector and industry breadth distinguish company-specific strength from a broad group move.
SectorZA Healthcare
4-week rank5 / 8
Group average7.2%
Trend breadth0.0%
Trend0.0%active weekly trend signals
MD12.5%positive activity pressure
RS12.5%positive relative leadership
Four-week leaders
IndustryZA Drug Manufacturers - Specialty & Generic
4-week rank2 / 3
Group average16.9%
Trend breadth0.0%
Trend0.0%active weekly trend signals
MD0.0%positive activity pressure
RS33.3%positive relative leadership
Four-week leaders
08 · Evidence and weekly data
The underlying research record
Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.
Weekly tape31/100
Trend, activity pressure, participation, and risk combine to a 31/100 tape read.
Indicator analysis23/100Latest 12-week confirmation: trend 2/12, activity pressure 2/12, relative leadership 2/12.
Activity pressure 0.23; No reversal markers Factors50/100No published factor snapshot is available yet.
Patient CapitalQuietActivity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal Sentiment51/100Weighted news tone is neutral across 20 relevant articles.
Aspen Pharmacare Holdings Limited Revenue Breakdown – JSE:APN Insiders50/100No recent insider transaction evidence is stored.
Earnings50/100No stored earnings event is currently attached to this ticker.
| Week | Close | Return | Trend Line | Fair Value | Pressure | Leadership | Volume | Trend |
|---|---|---|---|---|---|---|---|---|
| 7 Aug 2026 | 152.2 ZAC | 2.1% | 8,768 ZAC | 15,253 ZAC | -0.88 | -98.42 | 5.2M | Off |
| 31 Jul 2026 | 149.1 ZAC | 2.1% | 9,154 ZAC | 15,379 ZAC | -0.96 | -98.41 | 5.4M | Off |
| 24 Jul 2026 | 146.0 ZAC | -2.9% | 9,527 ZAC | 15,501 ZAC | -1.15 | -98.46 | 6.1M | Off |
| 17 Jul 2026 | 150.3 ZAC | -0.5% | 9,838 ZAC | 15,624 ZAC | -1.38 | -98.45 | 4.7M | Off |
| 10 Jul 2026 | 151.1 ZAC | -4.2% | 10,157 ZAC | 15,745 ZAC | -1.56 | -98.49 | 5.1M | Off |
| 3 Jul 2026 | 157.7 ZAC | 1.9% | 10,465 ZAC | 15,862 ZAC | -1.73 | -98.48 | 929.4K | Off |
| 26 Jun 2026 | 154.8 ZAC | 0.4% | 10,776 ZAC | 15,975 ZAC | -1.78 | -98.53 | 620.8K | Off |
| 19 Jun 2026 | 154.2 ZAC | 5.3% | 11,088 ZAC | 16,092 ZAC | -1.32 | -98.60 | 2.5M | Off |
| 12 Jun 2026 | 146.5 ZAC | 1.2% | 11,387 ZAC | 16,208 ZAC | -0.97 | -98.70 | 540.6K | Off |
| 5 Jun 2026 | 144.7 ZAC | -99.0% | 11,699 ZAC | 16,328 ZAC | -0.39 | -98.73 | 901.5K | Off |
| 29 May 2026 | 14,474 ZAC | 6.8% | 12,017 ZAC | 16,442 ZAC | 0.40 | 20.18 | 3.5M | On |
| 22 May 2026 | 13,549 ZAC | -3.5% | 11,862 ZAC | 16,461 ZAC | 0.60 | 13.86 | 3.7M | On |
| 15 May 2026 | 14,045 ZAC | -4.2% | 11,751 ZAC | 16,486 ZAC | 0.93 | 16.49 | 6.1M | On |
| 8 May 2026 | 14,665 ZAC | 5.5% | 11,618 ZAC | 16,503 ZAC | 1.00 | 17.99 | 9.6M | On |
How to use this report
This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.